Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
The Oncology Institute, Inc. (NASDAQ: TOI)
TOI Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
18.90%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
-21.20%
TOI Stock Analysis
TOI
PE Ratio:
TOI
PEG Ratio:
Not Available
TOI
Forward EPS Growth (12 month):
0.00%
TOI
PS Ratio:
0.8
TOI
PSG Ratio:
TOI
Forward Revenue Growth (12 month):
24.80%
TOI Articles
No data was found